Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price rose 14.1% during trading on Saturday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). Approximately 9,747,062 shares traded hands during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).
Analysts Set New Price Targets
SPI has been the topic of several analyst reports. Berenberg Bank reaffirmed a "buy" rating and set a GBX 280 target price on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. lowered their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.
Get Our Latest Report on SPI
Spire Healthcare Group Trading Up 14.1%
The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The firm has a market capitalization of £993.86 million, a price-to-earnings ratio of 5,369.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a 50-day moving average price of GBX 218.75 and a 200-day moving average price of GBX 203.56.
Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.